121 related articles for article (PubMed ID: 27568376)
1. In silico studies of the interaction between BRN2 protein and MORE DNA.
do Vale Coelho IE; Arruda DC; Taranto AG
J Mol Model; 2016 Sep; 22(9):228. PubMed ID: 27568376
[TBL] [Abstract][Full Text] [Related]
2. Peptide R18H from BRN2 Transcription Factor POU Domain Displays Antitumor Activity In Vitro and In Vivo and Induces Apoptosis in B16F10-Nex2 Cells.
da Cunha FFM; Mugnol KCU; de Melo FM; Nascimento MVSQ; de Azevedo RA; Santos RTS; Magalhães JA; Miguel DC; Tada DB; Mortara RA; Travassos LR; Arruda DC
Anticancer Agents Med Chem; 2019; 19(3):389-401. PubMed ID: 30417795
[TBL] [Abstract][Full Text] [Related]
3. BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.
Herbert K; Binet R; Lambert JP; Louphrasitthiphol P; Kalkavan H; Sesma-Sanz L; Robles-Espinoza CD; Sarkar S; Suer E; Andrews S; Chauhan J; Roberts ND; Middleton MR; Gingras AC; Masson JY; Larue L; Falletta P; Goding CR
Genes Dev; 2019 Mar; 33(5-6):310-332. PubMed ID: 30804224
[TBL] [Abstract][Full Text] [Related]
4. SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells.
Flammiger A; Besch R; Cook AL; Maier T; Sturm RA; Berking C
J Invest Dermatol; 2009 Apr; 129(4):945-53. PubMed ID: 18923447
[TBL] [Abstract][Full Text] [Related]
5. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.
Simmons JL; Pierce CJ; Al-Ejeh F; Boyle GM
Sci Rep; 2017 Sep; 7(1):10909. PubMed ID: 28883623
[TBL] [Abstract][Full Text] [Related]
6. BRN2, a POUerful driver of melanoma phenotype switching and metastasis.
Fane ME; Chhabra Y; Smith AG; Sturm RA
Pigment Cell Melanoma Res; 2019 Jan; 32(1):9-24. PubMed ID: 29781575
[TBL] [Abstract][Full Text] [Related]
7. Expression and purification of human full-length N Oct-3, a transcription factor involved in melanoma growth.
Cabos-Siguier B; Steunou AL; Joseph G; Alazard R; Ducoux-Petit M; Nieto L; Monsarrat B; Erard M; Clottes E
Protein Expr Purif; 2009 Mar; 64(1):39-46. PubMed ID: 18996486
[TBL] [Abstract][Full Text] [Related]
8. POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis.
Cook AL; Sturm RA
Pigment Cell Melanoma Res; 2008 Dec; 21(6):611-26. PubMed ID: 18983536
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene.
Kobi D; Steunou AL; Dembélé D; Legras S; Larue L; Nieto L; Davidson I
Pigment Cell Melanoma Res; 2010 Jun; 23(3):404-18. PubMed ID: 20337985
[TBL] [Abstract][Full Text] [Related]
10. Fine-tuning of intrinsic N-Oct-3 POU domain allostery by regulatory DNA targets.
Alazard R; Mourey L; Ebel C; Konarev PV; Petoukhov MV; Svergun DI; Erard M
Nucleic Acids Res; 2007; 35(13):4420-32. PubMed ID: 17576670
[TBL] [Abstract][Full Text] [Related]
11. BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells.
Ellmann L; Joshi MB; Resink TJ; Bosserhoff AK; Kuphal S
Lab Invest; 2012 Dec; 92(12):1788-800. PubMed ID: 23069940
[TBL] [Abstract][Full Text] [Related]
12. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
Ishii J; Sato H; Sakaeda M; Shishido-Hara Y; Hiramatsu C; Kamma H; Shimoyamada H; Fujiwara M; Endo T; Aoki I; Yazawa T
Pathol Int; 2013 Mar; 63(3):158-68. PubMed ID: 23530560
[TBL] [Abstract][Full Text] [Related]
13. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
Boyle GM; Woods SL; Bonazzi VF; Stark MS; Hacker E; Aoude LG; Dutton-Regester K; Cook AL; Sturm RA; Hayward NK
Pigment Cell Melanoma Res; 2011 Jun; 24(3):525-37. PubMed ID: 21435193
[TBL] [Abstract][Full Text] [Related]
14. Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway.
Thurber AE; Douglas G; Sturm EC; Zabierowski SE; Smit DJ; Ramakrishnan SN; Hacker E; Leonard JH; Herlyn M; Sturm RA
Oncogene; 2011 Jul; 30(27):3036-48. PubMed ID: 21358674
[TBL] [Abstract][Full Text] [Related]
15. Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3.
Cook AL; Donatien PD; Smith AG; Murphy M; Jones MK; Herlyn M; Bennett DC; Leonard JH; Sturm RA
J Invest Dermatol; 2003 Nov; 121(5):1150-9. PubMed ID: 14708619
[TBL] [Abstract][Full Text] [Related]
16. Peptide L13S Derived from the BRN2 POU Domain Reduces Metastasis
Cesar MCM; Mortara RA; Souza VS; Alves VRG; Paschoalin T; Soufen MA; DE Freitas GM; DA Cunha FFM; Tada DB; Dobroff AS; Arruda DC
Anticancer Res; 2024 Jan; 44(1):71-84. PubMed ID: 38160013
[TBL] [Abstract][Full Text] [Related]
17. Structure of the Oct-3 POU-homeodomain in solution, as determined by triple resonance heteronuclear multidimensional NMR spectroscopy.
Morita EH; Shirakawa M; Hayashi F; Imagawa M; Kyogoku Y
Protein Sci; 1995 Apr; 4(4):729-39. PubMed ID: 7613470
[TBL] [Abstract][Full Text] [Related]
18. BRN2 expression increases anoikis resistance in melanoma.
Pierce CJ; Simmons JL; Broit N; Karunarathne D; Ng MF; Boyle GM
Oncogenesis; 2020 Jul; 9(7):64. PubMed ID: 32632141
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal Regulation of BRN2 and NOTCH1/2 Signaling Synergistically Drives Melanoma Cell Migration and Invasion.
Fane ME; Chhabra Y; Spoerri L; Simmons JL; Ludwig R; Bonvin E; Goding CR; Sturm RA; Boyle GM; Haass NK; Piper M; Smith AG
J Invest Dermatol; 2022 Jul; 142(7):1845-1857. PubMed ID: 34958806
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of the neural development transcription factors (TTF1, ASCL1 and BRN2) in neuroendocrine prostate tumours.
Rodríguez-Zarco E; Vallejo-Benítez A; Umbría-Jiménez S; Pereira-Gallardo S; Pabón-Carrasco S; Azueta A; González-Cámpora R; Espinal PS; García-Escudero A
Actas Urol Esp; 2017 Oct; 41(8):529-534. PubMed ID: 28285791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
